Boston Scientific (BSX) Stock Moves -0.03%: What You Should Know

Yahoo Finance07:00

Morgan Stanley Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $100

Futu NewsDec 17 09:31 · Ratings

Optimistic Outlook for Boston Scientific's Urology Segment Drives Buy Recommendation

TipRanksDec 17 08:55

FDA Roundup: December 17, 2024

US FDADec 17 08:00

JP Morgan Maintains Overweight on Boston Scientific, Raises Price Target to $110

BenzingaDec 17 00:51 · Ratings

FDA Alerting About Potential Need For Early Device Replacement Of Boston Scientific Accolade Pacemaker Devices; Boston Scientific Announced Recall For Subset Of Accolade Pacemaker Devices With Increased Risk To Permanently Enter Safety Mode

BenzingaDec 17 00:25